2[1]Voermans C,Rood PML,Hordijk PL,et al.Adhesion molecules involved in transenthelial migration of human hematopoietic progenitor cells.Stem Cells,2000,18:435-443
3[2]Peled A,Kollet O,Ponomaryov T,et al.The chemokine SDF-1 activates the integrins LFA-1,VLA-4,and VLA-5 on immature human CD34 (+) cells: role in transenthelial/stromal migration and engraftment of NOD/SCID mice.Blood,2000,95:3289-3296
5[4]Leavesley DI,Oliver JM,Swart BW,et al.Signals from platelet/endothelial cell adhesion molecule enhance the adhesion activity of the very late antigen-4 integrin of human CD34+ hemopoietic progenitor cells.J Immunol,1994,153:4673-4683
6[5]Qiu L,Meagher R,Herzig RH,et al.Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serumfree medium (QBSF-60) with early effect cytokines.J Hematotherapy Stem Cell Res,1999,8 (6):609-618
7[6]Asosingh K,Renmans W,van der Gucht K,et al.Criculating CD34+ cells in cord blood and mobilized blood have a different profile of adhesion molecules than bone marrow CD34+ cells.Eur J Haematol,1998,60:153-160
8[7]Gazitt Y.Immunologic profiles of effector cells and periph eral blood stem cells mobilized with different hematopoietic growth factors.Stem Cells,2000,18:390-398
9[8]Dercksen MW,Geritsen WR,Rodenhuis S,et al.Expression of adhesion molecules on CD34+ cells: CD34+L-selectin+ cells predict a rapid platelet recovery after peripheral blood stem cell transplantation.Blood,1995,85:3313-3319
10[9]Yong KL,Watts M,Shaun Tho~nas N,et al.Transmigration of CD34+ cells across specialized and nonspecialized endothelium requires prior activation by growth factors and is mediated by PECAM-1 (CD31).Blood,1998.91:11961205
4Williams RL, Hilton DJ, Pease S, Willson TA, Stewart CL, Gearing DP, Wagner EF, Metcalf D, Nicola NA, Gough NM. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 1988; 336: 684-687.
5Smith AG, Heath JK, Donaldson DD, Wong GG, Moreau J, Stahl M, Rogers D. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 1988; 336: 688-690 .
6Yasunaga M, Tada S, Torikai-Nishikawa S, Nakano Y, Okada M, Jakt LM, Nishikawa S, Chiba T, Era T, Nishikawa S. Induction and monitoring of definitive and visceral endoderm differentiation of mouse ES cells. Nat Biotechnol 2005; 23: 1542-1550 .
7Kubo A, Shinozaki K, Shannon JM, Kouskoff V, Kennedy M, Woo S, Fehling HJ, Keller G. Development of definitive endoderm from embryonic stem cells in culture. Development 2004; 131: 1651-1662 .
8Gouon-Evans V, Boussemart L, Gadue P, Nierhoff D, Koehler CI, Kubo A, Shafritz DA, Keller G. BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat Biotechnol 2006; 24: 1402-1411.
9Shiraki N, Umeda K, Sakashita N, Takeya M, Kume K, Kume S. Differentiation of mouse and human embryonic stem cells into hepatic lineages. Genes Cells 2008; 13: 731-746 .
10Shiraki N, Yoshida T, Araki K, Umezawa A, Higuchi Y, Goto H, Kume K, Kume S. Guided differentiation of embryonic stem cells into Pdx1-expressing regional-specific definitive endoderm. Stem Cells 2008; 26: 874-885 .
